Finance

Lists
Why is QIA up 2,65%?
Dive Deeper
QIA:FRA
Qiagen NV
40,42 €
+2,65%
(+1,05) 1D
9-окт., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for QIA...
Open
39,54 €
High
40,56 €
Low
39,54 €
Mkt. cap
8,42 млд
Avg. vol.
615,00
Volume
141,00
Dividend
0,76%
Quarterly dividend
0,08 €
Ex-dividend date
2026-ж., 7-июл.
P/E ratio
23,28
52-wk high
48,80 €
52-wk low
27,86 €
EPS
1,74 €
Shares outstanding
226,24 млн
No. of employees
6 миң
Open
39,54 €
High
40,56 €
Low
39,54 €
Mkt. cap
8,42 млд
Avg. vol.
615,00
Volume
141,00
Dividend
0,76%
Quarterly dividend
0,08 €
Ex-dividend date
2026-ж., 7-июл.
P/E ratio
23,28
52-wk high
48,80 €
52-wk low
27,86 €
EPS
1,74 €
Shares outstanding
226,24 млн
No. of employees
6 миң
News stories
From web sources and news partners
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5,5 миң
Founded1984-ж., 29-ноя.
HeadquartersVenlo, Limburg, Нидерланддар
SectorHealth care
Websiteqiagen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
532,58 млн
540,42 млн
492,32 млн
535,04 млн
Cost of goods sold
187,78 млн
173,92 млн
168,83 млн
181,97 млн
Cost of revenue
187,78 млн
173,92 млн
168,83 млн
181,97 млн
Research and development expenses
48,75 млн
47,24 млн
48,26 млн
50,43 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
143,11 млн
153,88 млн
142,39 млн
146,77 млн
Operating expense
207,51 млн
218,30 млн
206,24 млн
212,22 млн
Total operating expenses
395,29 млн
392,22 млн
375,06 млн
394,19 млн
Operating income
137,29 млн
148,20 млн
117,26 млн
140,85 млн
Other non operating income
-89,00 миң
-133,00 миң
193,00 миң
-35,00 миң
EBT including unusual items
134,73 млн
109,17 млн
85,83 млн
132,10 млн
EBT excluding unusual items
142,86 млн
157,94 млн
118,66 млн
140,05 млн
Income tax expense
4,68 млн
1,34 млн
17,79 млн
28,70 млн
Effective tax rate
3,48%
1,23%
20,72%
21,73%
Other operating expenses
-
-
-
-
Net income
130,04 млн
107,83 млн
68,04 млн
103,40 млн
Net profit margin
24,42%
19,95%
13,82%
19,33%
Earnings per share
-
0,62
0,54
0,62
Interest and investment income
15,07 млн
20,00 млн
10,56 млн
9,36 млн
Interest expense
-8,22 млн
-10,14 млн
-11,05 млн
-10,02 млн
Net interest expenses
6,85 млн
9,86 млн
-489,00 миң
-661,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
188,26 млн
179,60 млн
168,47 млн
191,40 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору